233 related articles for article (PubMed ID: 16125255)
41. [Post-transplantation lymphoproliferation in patients with intensive immunosuppression].
Vavrinová H; Viklický O; Lácha J; Housa D; Hosková L; Teplan V
Vnitr Lek; 2006 Jun; 52(6):645-8. PubMed ID: 16871771
[TBL] [Abstract][Full Text] [Related]
42. Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR.
Michelson P; Watkins B; Webber SA; Wadowsky R; Michaels MG
Pediatr Transplant; 2008 Jun; 12(4):464-8. PubMed ID: 18466434
[TBL] [Abstract][Full Text] [Related]
43. Posttransplant lymphoproliferative disorder: morphological picture and diagnostic difficulties.
Ziarkiewicz-Wróblewska B; Górnicka B; Suleiman W; Ołdakowska-Jedynak U; Wróblewski T; Bogdańska M; Ziółkowski J; Nowacka-Cieciura E; Foroncewicz B; Pileri SA; Durlik M; Paczek L; Krawczyk M; Wasiutyński A
Transplant Proc; 2006; 38(1):168-72. PubMed ID: 16504694
[TBL] [Abstract][Full Text] [Related]
44. Posttransplant lymphoproliferative disorder: a pictorial review.
Burney K; Bradley M; Buckley A; Lyburn I; Rye A; Hopkins R
Australas Radiol; 2006 Oct; 50(5):412-8. PubMed ID: 16981935
[TBL] [Abstract][Full Text] [Related]
45. Adenotonsillar enlargement in pediatric organ transplant recipients: a cross-sectional analysis.
Chiang S; Vu MC; Nguyen M; Strocker A; Horvath S; Shapiro N
Otolaryngol Head Neck Surg; 2002 Jul; 127(1):109-14. PubMed ID: 12161739
[TBL] [Abstract][Full Text] [Related]
46. Optimal utilization of histopathologic analysis of tonsil and adenoid specimens in the pediatric population.
Sturm-O'Brien AK; Hicks JM; Giannoni CM; Sulek M; Friedman EM
Int J Pediatr Otorhinolaryngol; 2010 Feb; 74(2):161-3. PubMed ID: 19944467
[TBL] [Abstract][Full Text] [Related]
47. Heart allograft involvement by posttransplant lymphoproliferative disorders: report from the PTLD. Int survey.
Khedmat H; Taheri S
Exp Clin Transplant; 2011 Aug; 9(4):258-64. PubMed ID: 21819371
[TBL] [Abstract][Full Text] [Related]
48. Trends in invasive disease due to Candida species following heart and lung transplantation.
Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
[TBL] [Abstract][Full Text] [Related]
49. Posttransplant lymphoproliferative disorder.
Everly MJ; Bloom RD; Tsai DE; Trofe J
Ann Pharmacother; 2007 Nov; 41(11):1850-8. PubMed ID: 17940127
[TBL] [Abstract][Full Text] [Related]
50. Posttransplant lymphoproliferative disorder presenting in the head and neck.
Lattyak BV; Rosenthal P; Mudge C; Roberts JP; Renze JF; Osorio RW; Emond JC; Lalwani AK
Laryngoscope; 1998 Aug; 108(8 Pt 1):1195-8. PubMed ID: 9707243
[TBL] [Abstract][Full Text] [Related]
51. Eosinophilic esophagitis in children following cardiac transplantation: association with post-transplant lymphoproliferative disorder and other transplant outcomes.
Kindel SJ; Joy BF; Pahl E; Wald EL
Pediatr Transplant; 2014 Aug; 18(5):491-6. PubMed ID: 24931365
[TBL] [Abstract][Full Text] [Related]
52. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.
Buell JF; Gross TG; Hanaway MJ; Trofe J; Roy-Chaudhury P; First MR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):954-5. PubMed ID: 15848587
[TBL] [Abstract][Full Text] [Related]
53. Infectious, malignant, and autoimmune complications in pediatric heart transplant recipients.
Kulikowska A; Boslaugh SE; Huddleston CB; Gandhi SK; Gumbiner C; Canter CE
J Pediatr; 2008 May; 152(5):671-7. PubMed ID: 18410772
[TBL] [Abstract][Full Text] [Related]
54. Comparison of polygraphic parameters in children with adenotonsillar hypertrophy with vs without obstructive sleep apnea.
Zhang XW; Li Y; Zhou F; Guo CK; Huang ZT
Arch Otolaryngol Head Neck Surg; 2007 Feb; 133(2):122-6. PubMed ID: 17309978
[TBL] [Abstract][Full Text] [Related]
55. Head and neck infections in pediatric cardiac transplant patients.
Haddad J; Inglesby TV; Addonizio L
Ear Nose Throat J; 1995 Jun; 74(6):422-5. PubMed ID: 7628334
[TBL] [Abstract][Full Text] [Related]
56. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
[TBL] [Abstract][Full Text] [Related]
57. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B
Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109
[TBL] [Abstract][Full Text] [Related]
58. Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus.
Koch DG; Christiansen L; Lazarchick J; Stuart R; Willner IR; Reuben A
Liver Transpl; 2007 Jun; 13(6):904-12. PubMed ID: 17539010
[TBL] [Abstract][Full Text] [Related]
59. Chemotherapy for posttransplant lymphoproliferative disorder: the Israel Penn International Transplant Tumor Registry experience.
Buell JF; Gross TG; Hanaway MJ; Trofe J; Muthiak C; First MR; Alloway RR; Woodle ES
Transplant Proc; 2005 Mar; 37(2):956-7. PubMed ID: 15848588
[TBL] [Abstract][Full Text] [Related]
60. Graft coronary disease in pediatric heart and combined heart-lung transplant recipients: a study of fifteen cases.
Berry GJ; Rizeq MN; Weiss LM; Billingham ME
J Heart Lung Transplant; 1993; 12(6 Pt 2):S309-19. PubMed ID: 8312350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
